ABUS Earnings Arbutus Biopharma Corp
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–39 of 39
| Q2 2026 | 2026-06-30 | 0.84 | 2026-08-12 | 10-Q |
| Q1 2026 | 2026-03-31 | 0.87 | 2026-05-13 | 10-Q |
| FY 2025 | 2025-12-31 | -0.17 | 2026-03-23 | 10-K |
| Q3 2025 | 2025-09-30 | -0.16 | 2025-11-13 | 10-Q |
| Q2 2026 | 2025-06-30 | -0.12 | 2026-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.13 | 2026-05-13 | 10-Q |
| FY 2025 | 2024-12-31 | -0.38 | 2026-03-23 | 10-K |
| Q3 2025 | 2024-09-30 | -0.31 | 2025-11-13 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.21 | 2025-08-06 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.10 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -0.44 | 2025-03-27 | 10-K |
| Q3 2024 | 2023-09-30 | -0.32 | 2024-11-06 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.20 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.10 | 2024-05-02 | 10-Q |
| FY 2023 | 2022-12-31 | -0.46 | 2024-03-05 | 10-K |
| Q3 2023 | 2022-09-30 | -0.32 | 2023-11-07 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.20 | 2023-08-03 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.11 | 2023-05-04 | 10-Q |
| FY 2022 | 2021-12-31 | -0.83 | 2023-03-02 | 10-K |
| Q3 2022 | 2021-09-30 | -0.68 | 2022-11-09 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.44 | 2022-08-04 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.21 | 2022-05-05 | 10-Q |
| FY 2021 | 2020-12-31 | -1.00 | 2022-03-03 | 10-K |
| Q3 2021 | 2020-09-30 | -0.77 | 2021-11-04 | 10-Q |
| Q2 2021 | 2020-06-30 | -0.49 | 2021-08-05 | 10-Q |
| Q1 2021 | 2020-03-31 | -0.25 | 2021-05-05 | 10-Q |
| Q2 2019 | 2019-06-30 | -0.92 | 2019-08-05 | 10-Q |
| FY 2018 | 2018-12-31 | -1.21 | 2019-03-07 | 10-K |
| FY 2018 | 2018-09-30 | -0.49 | 2019-03-07 | 10-K |
| Q2 2019 | 2018-06-30 | -0.35 | 2019-08-05 | 10-Q |
| FY 2018 | 2018-03-31 | -0.36 | 2019-03-07 | 10-K |
| FY 2018 | 2017-12-31 | -1.56 | 2019-03-07 | 10-K |
| Q2 2018 | 2017-06-30 | -0.68 | 2018-08-03 | 10-Q |
| FY 2017 | 2016-12-31 | -7.24 | 2018-03-16 | 10-K |
| FY 2017 | 2015-12-31 | -1.38 | 2018-03-16 | 10-K |
| FY 2016 | 2014-12-31 | -1.80 | 2017-03-22 | 10-K |
| FY 2015 | 2013-12-31 | -0.92 | 2016-03-09 | 10-K |
| FY 2014 | 2012-12-31 | 2.07 | 2015-03-13 | 10-K |
| FY 2013 | 2011-12-31 | -0.89 | 2014-03-28 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.